The Mississippi Delta Health Collaborative Medication Therapy Management Model: Public Health and Pharmacy Working Together to Improve Population Health in the Mississippi Delta

Leigh Ann Ross

doi:10.5888/pcd17.200063

The Mississippi Delta Health Collaborative Medication Therapy Management Model: Public Health and Pharmacy Working Together to Improve Population Health in the Mississippi Delta

ORIGINAL RESEARCH — Volume 17 — September 17, 2020

Print

PEER REVIEWED

Figure. Classification of disease states, by severity, Mississippi Delta Health Collaborative Medication Therapy Management Model, 2009–2018. Hypertension staging was based on clinical guidelines from the 8th Joint National Committee for the Management of Hypertension in Adults (31). Abbreviation: —, not applicable.

Classification of disease states, by severity, Mississippi Delta Health Collaborative Medication Therapy Management Model, 2009–2018. Hypertension staging was based on clinical guidelines from the 8th Joint National Committee for the Management of Hypertension in Adults (31). Abbreviation: —, not applicable.
Clinical Measure	Normal	Elevated	Severely Elevated
Clinical Measure	Normal	Elevated	Stage I	Stage II	Stage III and IV
Systolic blood pressure, mm Hg^a	≤120	121–139	140–159	160–179	≥180
Diastolic blood pressure, mm Hg^a	≤80	81–89	90–99	100–109	≥110
Hemoglobin A1c (%)	4–6.9	7–9.9	10+
	Normal	Above Normal	Borderline	High	Very High
Low-density lipoprotein, mg/dL	<100	100–129	130–159	160–189	≥190
	Normal	Borderline	High	Very High
Triglyceride, mg/dL	<150	150–199	200–499	≥500
Total cholesterol, mg/dL	<200	200–239	≥240	—

Return to Article

Top

Error processing SSI file

The opinions expressed by authors contributing to this journal do not necessarily reflect the opinions of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors’ affiliated institutions.